Chime Biologics successfully passed the pre-approval inspection (PAI) conducted by the NMPA, realizing a leap to commercial manufacturing

鼎康生物与麦济生物签署战略合作,助力呼吸/免疫领域创新生物药驶入快车道

Cytiva与鼎康生物宣布开展GMP-2扩建项目合作

鼎康生物与斯微生物达成战略合作协议

Chime Biologics announced the expansion of GMP manufacturing capacity with construction of a second GMP facility (GMP-2)

Humanigen and Chime Biologics Enter Into Manufacturing Agreement for COVID-19 Therapeutic Candidate Lenzilumab